Intervening TNF-α via PPARγ with Gegenqinlian Decoction in Experimental Nonalcoholic Fatty Liver Disease

Intervening TNF-α via PPARγ with Gegenqinlian Decoction in Experimental Nonalcoholic Fatty Liver Disease

This paper is to explore the effect and mechanism of Gegenqinlian decoction on experimental nonalcoholic fatty liver disease (NAFLD) in vivo and in vitro. The final aim is to make clear whether Gegenqinlian decoction would impact NAFLD through improving PPARγ to suppress inflammation and regulate li...

Full description

Bibliographic Details
Main Authors:	Yun-liang Wang, Li-juan Liu, Wei-han Zhao, Jun-xiang Li
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	Evidence-Based Complementary and Alternative Medicine
Online Access:	http://dx.doi.org/10.1155/2015/715638

Similar Items

Optimizing the preparation methods of Gegenqinlian decoction with the assessments of its efficacy and safety
by: Shu-Hao Chang, et al.
Published: (2011)

Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
by: Jiayao Yang, et al.
Published: (2020-01-01)

Network Pharmacology-Based Analysis of Gegenqinlian Decoction Regulating Intestinal Microbial Activity for the Treatment of Diarrhea
by: Xiaoya Li, et al.
Published: (2021-01-01)

Association between PPARγ gene rs3856806 polymorphism and nonalcoholic fatty liver disease
by: XU Xin, et al.
Published: (2015-07-01)

Hsp90 modulates PPARγ activity in a mouse model of nonalcoholic fatty liver disease[S]
by: Matthew C. Wheeler, et al.
Published: (2014-08-01)

The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
by: Divya P. Kumar, et al.
Published: (2020-06-01)

PPARα and PPARγ as main regulators of fatty acid metabolism
by: Mirosław Kucharski, et al.
Published: (2018-10-01)

Metabonomic analysis of plasma biochemical changes in pyrexia rats after treatment with Gegenqinlian decoction, aspirin and itraconazole by UHPLC-FT-ICR-MS
by: Ting Liu, et al.
Published: (2020-12-01)

Sini decoction intervention on atherosclerosis via PPARγ-LXRα-ABCA1 pathway in rabbits
by: Ju Shicong, et al.
Published: (2018-11-01)

Hua-Zhuo-Kai-Yu decoction inhibits apoptosis in nonalcoholic fatty liver disease
by: Yu-Ting Li, et al.
Published: (2021-01-01)

Yinchen Linggui Zhugan Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats by Regulating the Nrf2/ARE Signaling Pathway
by: Yi Guo, et al.
Published: (2017-01-01)

Shugan Xiaozhi Decoction Attenuates Nonalcoholic Steatohepatitis by Enhancing PPARα and L-FABP Expressions in High-Fat-Fed Rats
by: Yu-feng Xing, et al.
Published: (2016-01-01)

Gastrodin Reduces Blood Pressure by Intervening with RAAS and PPARγ in SHRs
by: Wei Liu, et al.
Published: (2015-01-01)

Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients of cardiovascular diseases and its association with hs-CRP and TNF-α
by: Masihur Rehman Ajmal, et al.
Published: (2014-11-01)

Idebenone and coenzyme Q10 are novel PPARα/γ ligands, with potential for treatment of fatty liver diseases
by: Jens Tiefenbach, et al.
Published: (2018-09-01)

YiQi YangYin Decoction Attenuates Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Rats
by: Fengjin Li, et al.
Published: (2021-01-01)

Effects of Qutanhuoxue Decoction on AQP7 and AQP9 Expression in Nonalcoholic Fatty Liver Model Rats
by: Ding Zheng, et al.
Published: (2019-01-01)

Gegen Qinlian Decoction Coordinately Regulates PPARγ and PPARα to Improve Glucose and Lipid Homeostasis in Diabetic Rats and Insulin Resistance 3T3-L1 Adipocytes
by: Jun Tu, et al.
Published: (2020-06-01)

Effect of the adjuvant Baogan Jiangzhi decoction therapy on liver function and insulin sensitivity in patients with nonalcoholic fatty liver disease
by: Hong-Mei Qiang, et al.
Published: (2018-06-01)

Modes-of-Action Related to Repeated Dose Toxicity: Tissue-Specific Biological Roles of PPARγ Ligand-Dependent Dysregulation in Nonalcoholic Fatty Liver Disease
by: Merilin Al Sharif, et al.
Published: (2014-01-01)

PPARα/γ-Independent Effects of PPARα/γ Ligands on Cysteinyl Leukotriene Production in Mast Cells
by: Masamichi Yamashita
Published: (2008-01-01)

PPARγ ligand ciglitazone inhibits TNFα-induced ICAM-1 in human airway smooth muscle cells
by: Chien-Da Huang, et al.
Published: (2014-08-01)

Activation of the Peroxisome Proliferator-Activated Receptors (PPAR-α/γ) and the Fatty Acid Metabolizing Enzyme Protein CPT1A by Camel Milk Treatment Counteracts the High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease
by: Haifa M. AlNafea, et al.
Published: (2021-01-01)

Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation
by: Lei Wang, et al.
Published: (2020-01-01)

16S rRNA Technology Approach to Explore Mechanism of Qishen Decoction in Improving Nonalcoholic Fatty Liver Fibrosis
by: Bing-Yu Wang, et al.
Published: (2020-01-01)

Aspirin Improves Nonalcoholic Fatty Liver Disease and Atherosclerosis through Regulation of the PPARδ-AMPK-PGC-1α Pathway in Dyslipidemic Conditions
by: Yoon-Mi Han, et al.
Published: (2020-01-01)

Scaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptors.
by: Li-Song Zhang, et al.
Published: (2012-01-01)

Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions
by: Yong-Jik Lee, et al.
Published: (2017-01-01)

Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity
by: Luis A. Videla, et al.
Published: (2012-01-01)

Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex.
by: Justin A Lemkul, et al.
Published: (2015-01-01)

Curcumin promotes oligodendrocyte differentiation and their protection against TNF-α through the activation of the nuclear receptor PPAR-γ
by: Antonietta Bernardo, et al.
Published: (2021-03-01)

Influence of Rosiglitazone on the Expression of PPARγ, NF-κB, and TNF-α in Rat Model of Ulcerative Colitis
by: Jing-Wei Mao, et al.
Published: (2012-01-01)

Gegen Qinlian Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats via Oxidative Stress, Inflammation, and the NLRP3 Signal Axis
by: Yuqi Ying, et al.
Published: (2021-01-01)

Nonalcoholic Fatty Liver Disease
by: Bayard, Max, et al.
Published: (2006)

Nonalcoholic Fatty Liver Disease
by: Branka Filipović, et al.
Published: (2018-01-01)

Nonalcoholic fatty liver disease
by: Sandra K. Erickson
Published: (2009-01-01)

Nonalcoholic fatty liver disease
by: Lafaine M. Grant, et al.
Published: (2004-07-01)

Nonalcoholic fatty liver disease and hepatocellular carcinoma
by: LI Liangping
Published: (2016-03-01)

Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in human hepatocytes.
by: Alexandra Rogue, et al.
Published: (2011-01-01)

Studies on PPAR α and γ participating in progression of liver fibrosis by regulating ACSL1
by: XIN Xuan
Published: (2014-08-01)

Cannot write session to /tmp/vufind_sessions/sess_l72ro184lotnhav43906sj3ctr